Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit.
ICU Department, 'Saint Savvas' Oncology Hospital, Athens, Greece. Electronic address: linatsim18@gmail.com.
Angeliki
A
Tsimogianni
ICU Department, 'Saint Savvas' Oncology Hospital, Athens, Greece.
Panagiotis
P
Alexandropoulos
ICU Department, 'Saint Savvas' Oncology Hospital, Athens, Greece.
Vasiliki
V
Chantziara
ICU Department, 'Saint Savvas' Oncology Hospital, Athens, Greece.
Aimilia
A
Vassi
ICU Department, 'Saint Savvas' Oncology Hospital, Athens, Greece.
Georgia
G
Micha
ICU Department, 'Saint Savvas' Oncology Hospital, Athens, Greece.
Fotini
F
Lagiou
Microbiology Department, 'Saint Savvas' Oncology Hospital, Athens, Greece.
Efrosini
E
Chinou
ICU Department, 'Saint Savvas' Oncology Hospital, Athens, Greece.
Georgios
G
Michaloudis
ICU Department, 'Saint Savvas' Oncology Hospital, Athens, Greece.
Serafeim
S
Georgiou
D000583:Amikacin / Q000008:administration & dosage* / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002097:C-Reactive Protein / Q000032:analysis; D002494:Central Nervous System Infections / Q000097:blood / Q000188:drug therapy*; D003091:Colistin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007276:Injections, Intraventricular; D007278:Injections, Spinal; D007362:Intensive Care Units; D019635:Neurosurgical Procedures; D012189:Retrospective Studies; D014640:Vancomycin / Q000008:administration & dosage* / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D000583:Amikacin; D002097:C-Reactive Protein; D003091:Colistin